News Powered By:
– a collaborative partner.
CenterWatch News Online Headlines : April 24, 2015 9:11 am : Centerwatch
Mitotech, a Luxembourg-based clinical-stage biotechnology company developing novel antioxidant molecules targeting mitochondria, has achieved significant positive results in its U.S. phase II clinical trial of SkQ1 compound in patients with moderate to severe dry eye syndrome. SkQ1 is a small molecule engineered specifically for reducing oxidative stress inside mitochondria, which proved to be effective in a topical ophthalmic formulation for treatment of dry eye syndrome.
CenterWatch News Online Headlines : April 24, 2015 8:58 am : Centerwatch
Biohaven Pharmaceutical Holding is on schedule to initiate a phase I pharmacokinetic and biomarker study with its lead drug development candidate BHV-0223. Biohaven plans to initiate the trial no later than 3Q2015. After confirming projected drug exposure levels in the phase I study, Biohaven will move directly into a phase III registrational trial in affective disorders.
CenterWatch News Online Headlines : April 24, 2015 8:52 am : Centerwatch
Juniper Pharmaceuticals, a specialty pharmaceutical company focused on developing therapeutics that address unmet medical needs in women’s health, has created a scientific advisory board (SAB) comprised of international physicians and scientists whose mission will be to provide scientific and clinical advice on the identification and advancement of product candidates for Juniper’s women’s health portfolio.
CenterWatch News Online Headlines : April 24, 2015 8:43 am : Centerwatch
Partnerships in Clinical Trials has named Parexel’s Drew Garty, senior director, product management, the 2015 Clinical Innovator of the Year. The award recognizes Garty’s leadership of the product development team for the company’s Perceptive MyTrials Data-Driven Monitoring solution.
CenterWatch News Online Headlines : April 24, 2015 8:38 am : Centerwatch
BioClinica, a specialty clinical trials services and technology provider, has announced that Mukhtar Ahmed, a recognized business leader within the life sciences, healthcare and technology sectors, has joined BioClinica as president of its Global eClinical Business Unit.